India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects ...

Jeff Gordon reconnects with cancer survivor Cody Keeth after 25 years, showcasing kindness, lasting bonds, and his foundation ...

A New Jersey teen continued to play basketball even after he was diagnosed with stage 4B Hodgkin's lymphoma in July 2024 and ...

Abbie Colie is the type of person who gives without recognition and receives without forgetting. This time, though, the ...

A British woman who blamed her back pain on having E-cup breasts was self-medicating with paracetamol and ibuprofen for ...

“We are living in the dark ages,” said Robyn Spoon, a member of the coalition and CEO of Elevate Childhood Cancer Research ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...

A new report revealed a troubling shift in cancer demographics, with women and younger people now bearing a larger brunt of ...

The widow of an Air Force missileer who died of non-Hodgkin lymphoma has finally secured Department of Veterans Affairs ...

The widow of an Air Force missileer who died of non-Hodgkin lymphoma has finally secured Department of Veterans Affairs ...

Bayer, defended by Herbert Smith Freehills, said the McNickle judgment was the first Roundup final judgment outside the U.S.

Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.